Navigation Links
Advanced Life Sciences Announces Second Quarter 2008 Financial Results

Present posters and meet with National Advisory Board for

cethromycin at the October 25-28 ICAAC/IDSA conference in

Washington, DC;

* Under the DTRA contract, expand advanced studies of cethromycin as a

broad spectrum medical countermeasure;

* Continue preparing for commercial launch of cethromycin through

manufacturing, market research, medical education, and pricing

strategy activities;

* Dose first patient in ALS-357 PhaseI/II melanoma trial.

Financial Guidance for the Third Quarter of 2008

Advanced Life Sciences expects its third quarter 2008 cash requirements to fall in the range of $3.4 million and $3.7 million, leaving a cash balance of $5.4 million to $5.7 million as of September 30, 2008. Management believes that this cash balance will be sufficient to allow the Company to progress to the period in which it submits the NDA for cethromycin in the CAP indication to the FDA. To fund ongoing operations including the payment of any milestone payment due to Abbott Laboratories in connection with the submission of the cethromycin NDA, the Company intends to raise additional capital in 2008 through a commercial partnership and/or the sale of equity, if available at terms acceptable to us, which cannot be assured.

Conference Call Details

Advanced Life Sciences will host a conference call and live webcast at 10:00 a.m. Eastern Time on Thursday, August 14, 2008 to discuss the company's second quarter financial results.

The conference call will be webcast simultaneously over the Internet. Please visit the Investor Relations section of the Advanced Life Sciences corporate website Alternatively, callers may participate in the conference call by dialing 888-713-4218 (domestic) or 617-213-4870 (international). The passcode for the conference call is

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
(Date:4/21/2015)... discovery company, Novogen, today announced that its subsidiary joint ... received notification from the U.S. Food and Drug Administration ... granted Orphan Drug Designation for ovarian cancer. ... experimental drug and has been instigated in a number ... and Australia to encourage ...
(Date:4/21/2015)... 21, 2015 Simply “trying” to ensure ... is not enough, the European Commission’s Digital Agenda (DG ... ensuring that digital technologies help deliver the growth which ... will help ensure that women’s voices are heard ... the international society for optics and photonics , are ...
(Date:4/21/2015)... NEW YORK , April 21, 2015  This ... acquisition deals in the pharmaceuticals and biotechnology industry. The ... value. Trends are also observed based on the geographic ... nature of cross-border deals and takes into account various ... stock premium rise of the target company. ...
(Date:4/21/2015)... , April 21, 2015 The North American ... of 5.8% from 2014 to 2019. Based on geography, this ... , and Mexico . The U.S. ... Canada . The major factors driving the growth of ... industry. These industries are the prime users of chromatography techniques. ...
Breaking Biology Technology:Cantrixil Receives Orphan Drug Designation from FDA 2Cantrixil Receives Orphan Drug Designation from FDA 3Cantrixil Receives Orphan Drug Designation from FDA 4Cantrixil Receives Orphan Drug Designation from FDA 5Just to try is not enough, say organizations working to promote women in science and technology 2Just to try is not enough, say organizations working to promote women in science and technology 3Funding Patterns in the Global Pharma and Biotech Industry 2North American Chromatography systems Market by Types, & by End-Users - Forecast to 2019 2North American Chromatography systems Market by Types, & by End-Users - Forecast to 2019 3
... ET; 8:00 a.m. PT, VANCOUVER and SAN DIEGO, ... a clinical-stage developer of drugs for infectious,diseases, will host ... at 11:00 a.m. ET (8:00 a.m. PT) to discuss ... 2008 and provide an update on,company activities. To participate ...
... on Detroit Area, DETROIT, March 11 ... its new study, Affordable Broadband:,Empowering Communities Across the ... to education, health care and civic,involvement in minority ... Empowerment Council (DEC) that was launched,earlier this year ...
... March 11 Haemonetics,Corporation announced today the appointment ... Chief Marketing Officer. In this position, Mr. Allen,will ... portfolio in addition to his current responsibilities as ... commented, "Pete Allen was an,architect of our strategic ...
Cached Biology Technology:Study Finds Broadband Access Key to Empowerment of Minority Communities 2Haemonetics(R) Appoints Peter Allen as Chief Marketing Officer 2
(Date:4/21/2015)... BURNABY, Canada , April 21, 2015 ... spending and evolving government policies are boosting access control ...   According to a recently published report ... & Opportunities, 2020 ", the access control systems market ... to nearly USD1.2 billion by 2020.The access control systems ...
(Date:4/20/2015)... PASADENA, Calif. , April 20, 2015 ... San Gabriel Valley to implant a new miniaturized, wireless ... HF System is the first and only FDA-approved heart ... reduce hospital admissions when used by physicians to manage ... a sensor that is implanted in the pulmonary artery ...
(Date:4/20/2015)... , April 20, 2015 The ... Glenbeigh Records Management (GRM), Ireland,s ... Dubai Islamic Bank. Having built up an impressive track record ... a leading player within the records management sector in ... to double is GCC staffbase and employ a further eight ...
Breaking Biology News(10 mins):Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3
... the next big innovation in sustainable climate technology? ... for Business Law and Regulation at Case Western Reserve ... do just that. "Technology-induced prizes have a long ... on a Climate Prize Rewarding Energy Innovation to Achieve ...
... ST. AUGUSTINE, TRINIDAD AND TOBAGOFlower color in plants ... carotenoids. Research has found that the ultimate color displayed ... also on other factors, including cell shape, presence of ... role of pH in creating color has allowed plant ...
... Ill. Researchers have identified a protein long known to ... growth. Their study, in the journal Oncogene , is ... accomplishes this feat. "People suggested that Runx3 might be ... it is down-regulated in a lot of breast cancer cell ...
Cached Biology News:CWRU law professor eyes prize-based incentives to generate climate innovation 2Engineering blue-hued flowers 2Team identifies new breast cancer tumor suppressor and how it works 2
... Disrupts biological cells for DNA ... 96 well plates (includes 96 well ... consistent lysis across the entire plate ... wells). Can be used for ...
Request Info...
GBL Antibody...
Dnase and Rnase free...
Biology Products: